This is a preview of subscription content, log in via an institution to check access.
References
Schoots IG, Barentsz JO, Bittencourt LK et al (2021) PI-RADS Committee position on MRI without contrast medium in biopsy-naive men with suspected prostate cancer: narrative review. AJR Am J Roentgenol 216:3–19
Padhani AR, Schoots I, Villeirs G (2021) Contrast medium or no contrast medium for prostate cancer diagnosis. That is the question. J Magn Reson Imaging 53:13–22
Pecoraro M, Messina E, Bicchetti M et al (2021) The future direction of imaging in prostate cancer: MRI with or without contrast injection. Andrology 9:1429–1443
Belue MJ, Yilmaz EC, Daryanani A, Turkbey B (2022) Current status of biparametric MRI in prostate cancer diagnosis: literature analysis. Life 12:804
Turkbey B, Purysko AS (2023) PI-RADS: where next? Radiology. https://doi.org/10.1148/radiol.223128:223128
van der Leest M, Israel B, Cornel EB et al (2019) High diagnostic performance of short magnetic resonance imaging protocols for prostate cancer detection in biopsy-naive men: the next step in magnetic resonance imaging accessibility. Eur Urol 76:574–581
Stranne J, Mottet N, Rouviere O, EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines Panel (2023) Systematic biopsies as a complement to magnetic resonance imaging-targeted biopsies: "to be or not to be"? Eur Urol 83:381-384
Gatti M, Faletti R, Calleris G et al (2019) Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI). Abdom Radiol 44:1883–1893
Greer MD, Shih JH, Lay N et al (2017) Validation of the dominant sequence paradigm and role of dynamic contrast-enhanced imaging in PI-RADS version 2. Radiology 285:859–869
Rouviere O, Jaouen T, Baseilhac P et al (2023) Artificial intelligence algorithms aimed at characterizing or detecting prostate cancer on MRI: how accurate are they when tested on independent cohorts? - a systematic review. Diagn Interv Imaging 104:221–234
Hotker AM, Da Mutten R, Tiessen A, Konukoglu E, Donati OF (2021) Improving workflow in prostate MRI: AI-based decision-making on biparametric or multiparametric MRI. Insights Imaging 12:112
Funding
The author states that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Olivier Rouvière.
Conflict of interest
The author of this manuscript declares no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was not required for this study because it is just an editorial that do not use new patient data.
Ethical approval
Institutional Review Board approval was not required because the present paper is not an original study but an editorial.
Study subjects or cohorts overlap
N/A
Methodology
• Commentary
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Please also see the commentary available at https://doi.org/10.1007/s00330-023-09766-x
Rights and permissions
About this article
Cite this article
Rouvière, O. Contrast-medium administration for prostate MRI can be abandoned: no(t so simple)!. Eur Radiol 33, 8415–8416 (2023). https://doi.org/10.1007/s00330-023-09767-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-023-09767-x